MCT1: Proton-linked monocarboxylate transporter. Catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, branched-chain oxo acids derived from leucine, valine and isoleucine, and the ketone bodies acetoacetate, beta-hydroxybutyrate and acetate. Defects in SLC16A1 are the cause of symptomatic deficiency in lactate transport (SDLT); also known as erythrocyte lactate transporter defect. Deficiency of lactate transporter may result in an acidic intracellular environment created by muscle activity with consequent degeneration of muscle and release of myoglobin and creatine kinase. This defect might compromise extreme performance in otherwise healthy individuals. Defects in SLC16A1 are the cause of familial hyperinsulinemic hypoglycemia type 7 (HHF7); also known as exercise-induced hyperinsulinemic hypoglycemia. HHF7 is a dominantly inherited hypoglycemic disorder characterized by inappropriate insulin secretion during anaerobic exercise or on pyruvate load. Belongs to the major facilitator superfamily. Monocarboxylate porter (TC 2.A.1.13) family.
Protein type: Transporter, SLC family; Mitochondrial; Membrane protein, multi-pass; Membrane protein, integral; Transporter
Cellular Component: centrosome; integral to membrane; integral to plasma membrane; membrane; mitochondrion; plasma membrane
Molecular Function: lactate transmembrane transporter activity; monocarboxylic acid transmembrane transporter activity; protein homodimerization activity; symporter activity
Biological Process: behavioral response to nutrient; centrosome organization and biogenesis; glucose homeostasis; lipid metabolic process; monocarboxylic acid transport; regulation of insulin secretion; response to food; transmembrane transport; transport
Show more